| abstract |
The present application provides compounds for treating metabolic disorders and hyperproliferative disorders and methods of using these compounds, comprising administering the compounds in combination with hormone receptor antagonists. The present disclosure relates generally to therapeutic methods for the treatment of hyperproliferative disorders, metabolic disorders, and pancreatitis. The present disclosure provides compounds and methods of using these compounds for treating benign and malignant hyperproliferative disorders, as well as metabolic disorders and pancreatitis, as described below. The compounds of the present invention may also be used in the treatment of cancer. |